ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the rat (Q73199961)
Jump to navigation
Jump to search
scientific article published on 01 December 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the rat |
scientific article published on 01 December 2000 |
Statements
ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the rat (English)
Kowaluk EA
Mikusa J
Wismer CT
Zhu CZ
Schweitzer E
Lynch JJ
Lee CH
Jiang M
Bhagwat SS
Gomtsyan A
McKie J
Cox BF
Polakowski J
Reinhart G
Williams M